All Stories

  1. Managing Helicobacter pylori : elimination challenges

    Article • Therapeutic Advances in Gastroenterology, April 2025, SAGE Publications

    Dr Farid Rahimi

  2. Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori

    Article • BMC Research Notes, March 2025, Springer Science + Business Media

    Dr Farid Rahimi

  3. Reviving Iran’s Science Diplomacy: New Horizons Opened by President Pezeshkian

    Article • Archives of Iranian Medicine, January 2025, MaadRayan Publishing Company

    Dr Farid Rahimi

  4. ChatGPT and Corporations of Mega-journals Jeopardize the Norms That Underpin Academic Publishing

    Article • Archives of Iranian Medicine, February 2024, MaadRayan Publishing Company

    Dr Farid Rahimi

  5. SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19

    Article • Current Medicinal Chemistry, December 2023, Bentham Science Publishers

    Dr Farid Rahimi, Professor (Dr) Shailendra K Saxena, Dr Amos Lal

  6. Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis

    Article • Metabolites, October 2023, MDPI AG

    Dr Farid Rahimi

  7. Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis

    Article • September 2023, MDPI AG

    Dr Farid Rahimi

  8. ‘The end’ – Or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 Subvariants

    Article • Future Virology, September 2023, Taylor & Francis

    Dr Farid Rahimi

  9. Passive Contribution of ChatGPT to Scientific Papers

    Article • Annals of Biomedical Engineering, June 2023, Springer Science + Business Media

    Dr Farid Rahimi

  10. ChatGPT and Publication Ethics

    Article • Archives of Medical Research, April 2023, Elsevier

    Dr Farid Rahimi

  11. The prevalence of antibiotic-resistant Acinetobacter baumannii infections among the Iranian ICU patients: A systematic review and meta-analysis

    Article • Gene Reports, March 2023, Elsevier

    Dr Farid Rahimi

  12. Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic

    Article • International Journal of Surgery, December 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  13. Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer

    Article • BMC Research Notes, October 2022, Springer Science + Business Media

    Dr Farid Rahimi

  14. Poliomyelitis outbreaks caused by circulation of the vaccine-derived poliovirus

    Article • International Journal of Surgery, September 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  15. WHO declared monkeypox a public-health emergency of international concern: A case for prevention rationale

    Article • International Journal of Surgery, September 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  16. COVID-19 and science diplomacy

    Article • International Journal of Surgery, August 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  17. Immediate countermeasures against the monkeypox outbreak

    Article • International Journal of Surgery, August 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  18. Implications of the SARS-CoV-2 subvariants BA.4 and BA.5

    Article • International Journal of Surgery, August 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  19. The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries

    Article • International Journal of Surgery, August 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  20. Hybrid SARS-CoV-2 variants

    Article • International Journal of Surgery, June 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  21. The Ukrainian refugee crisis and the COVID-19 pandemic in Europe

    Article • International Journal of Surgery, June 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  22. Omicron: A highly transmissible SARS-CoV-2 variant

    Article • Gene Reports, June 2022, Elsevier

    Dr Farid Rahimi

  23. Detection of the XE subvariant of SARS-CoV-2: A perspective

    Article • International Journal of Surgery, May 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  24. Is Omicron the last SARS-CoV-2 Variant of Concern?

    Article • Archives of Medical Research, April 2022, Elsevier

    Dr Farid Rahimi

  25. Learning from Retracted Papers Authored by the Highly Cited Iran-affiliated Researchers: Revisiting Research Policies and a Key Message to Clarivate Analytics

    Article • Science and Engineering Ethics, April 2022, Springer Science + Business Media

    Dr Farid Rahimi

  26. Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic

    Article • International Journal of Surgery, March 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  27. WHO prequalified tocilizumab and vaccine boosters against COVID-19

    Article • International Journal of Surgery, March 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  28. The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic

    Article • International Journal of Surgery, March 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  29. A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant

    Article • International Journal of Surgery, February 2022, Wolters Kluwer Health

    Dr Farid Rahimi

  30. The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic

    Article • Future Virology, January 2022, Future Medicine

    Dr Farid Rahimi

  31. SARS-CoV-2 Lambda (C.37): An emerging variant of concern?

    Article • Gene Reports, December 2021, Elsevier

    Dr Farid Rahimi

  32. The third booster vaccination dose against COVID-19: indications for circulating SARS-CoV-2 variants

    Article • Future Virology, December 2021, Future Medicine

    Dr Farid Rahimi

  33. Emergence of the Delta Plus variant of SARS-CoV-2 in Iran

    Article • Gene Reports, December 2021, Elsevier

    Dr Farid Rahimi

  34. Isolation of dupA-positive and clarithromycin-resistant Helicobacter pylori from Iranian patients with duodenal ulcer

    Article • Gene Reports, September 2021, Elsevier

    Dr Farid Rahimi

  35. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01

    Article • Archives of Medical Research, July 2021, Elsevier

    Dr Farid Rahimi

  36. Identification of Helicobacter pylori in tumor biopsies obtained from patients with colorectal cancer: Indication for a prophylactic vaccine?

    Article • Vacunas (English Edition), May 2021, Elsevier

    Dr Farid Rahimi

  37. Identification of Helicobacter pylori in tumor biopsies obtained from patients with colorectal cancer: Indication for a prophylactic vaccine?

    Article • Vacunas, May 2021, Elsevier

    Dr Farid Rahimi

  38. Alzheimer Disease: Controversies in Basic Science Research, Different Theories, and Reasons for Failed Trials

    Article • Biomedicines, March 2021, MDPI AG

    Dr Farid Rahimi

  39. Plagiarism, Fake Peer-Review, and Duplication: Predominant Reasons Underlying Retractions of Iran-Affiliated Scientific Papers

    Article • Science and Engineering Ethics, November 2020, Springer Science + Business Media

    Dr Farid Rahimi

  40. Criticality of physical/social distancing, handwashing, respiratory hygiene and face‐masking during the COVID‐19 pandemic and beyond

    Article • International Journal of Clinical Practice, September 2020, Hindawi Publishing Corporation

    Dr Farid Rahimi

  41. Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in Plasmodium chabaudi but Not in Plasmodium berghei or Plasmodium falciparum During Intraerythrocytic Growth

    Article • Frontiers in Cellular and Infection Microbiology, September 2020, Frontiers

    Dr Farid Rahimi

  42. Challenges of managing the asymptomatic carriers of SARS-CoV-2

    Article • Travel Medicine and Infectious Disease, September 2020, Elsevier

    Dr Farid Rahimi

  43. The Uncertainties Underlying Herd Immunity against COVID-19

    Article • July 2020, MDPI AG

    Dr Farid Rahimi

  44. Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases

    Article • Research in Molecular Medicine, July 2020, Negah Scientific Publisher

    Dr Farid Rahimi

  45. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2

    Article • Archives of Medical Research, July 2020, Elsevier

    Dr Farid Rahimi

  46. Tackling the COVID-19 Pandemic

    Article • Archives of Medical Research, July 2020, Elsevier

    Dr Farid Rahimi

  47. Ethical and Sensible Dissemination of Information During the COVID-19 Pandemic

    Article • The American Journal of Bioethics, May 2020, Taylor & Francis

    Dr Farid Rahimi

  48. Criticality of physical/social distancing, handwashing, respiratory hygiene, and face-masking during the COVID-19 pandemic and beyond

    Article • May 2020, Authorea, Inc.

    Dr Farid Rahimi

  49. Unguided research and noncompliance may have intensified the COVID-19 pandemic

    Article • May 2020, Authorea, Inc.

    Dr Farid Rahimi

  50. <p>Colonization by <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> of Antral Biopsy Specimens from Gastritis Patients Uninfected with <em>Helicobacter Pylori</em></p>

    Article • Infection and Drug Resistance, May 2020, Taylor & Francis

    Dr Farid Rahimi

  51. Transparency and information sharing could help abate the COVID-19 pandemic

    Article • Infection Control, April 2020, Cambridge University Press

    Dr Farid Rahimi

  52. Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat

    Article • Archives of Medical Research, April 2020, Elsevier

    Dr Farid Rahimi

  53. FadA-positive Fusobacterium nucleatum is prevalent in the biopsy specimens of Iranian patients with colorectal cancer

    Article • New Microbes and New Infections, January 2020, Elsevier

    Dr Farid Rahimi

  54. Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer

    Article • BioNanoScience, November 2019, Springer Science + Business Media

    Dr Farid Rahimi

  55. Helicobacter heilmannii Colonization Is Associated With High Risk for Gastritis

    Article • Archives of Medical Research, October 2019, Elsevier

    Dr Farid Rahimi

  56. Present Challenges Besetting the Iranian Academia

    Article • Archives of Medical Research, October 2019, Elsevier

    Dr Farid Rahimi

  57. Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

    Article • Disease Markers, September 2019, Wiley

    Dr Farid Rahimi

  58. Host porphobilinogen deaminase deficiency confers malaria resistance in Plasmodium chabaudi but not in Plasmodium falciparum or Plasmodium berghei during intraerythrocytic growth

    Article • March 2019, Cold Spring Harbor Laboratory Press

    Dr Farid Rahimi

  59. Characterization of the ATP4 ion pump in Toxoplasma gondii

    Article • Journal of Biological Chemistry, February 2019, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Farid Rahimi

  60. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells

    Article • Journal of Biological Chemistry, January 2019, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Farid Rahimi

  61. Large expert-curated database for benchmarking document

    Article • Database, January 2019, Oxford University Press (OUP)

    Dr Daniel Prieto, Associate Professor James A.L. Brown, Professor Amanda G Thrift, Docent Kutty Selva Nandakumar, Professor Miguel Viveiros, MD Diego A. Valera-Cornejo, Dr Soroush Safaei, Dr Carmen San Martín, Piero Carninci, Dr Florian Rehfeldt, Dr Yoichi Watanabe, Kazuki Ide, Mr Alvin Wong, PD Dr. Adrian Meule, Dr Maurizio Petrelli, Dr Christine McGarrigle, Dr Tristan Reddan, Dr Nicola Roberts, Professor Stefan Lorkowski, Dr Cyrille Goarant, Dr Emma C Hobbs, Dr. Saurab Sharma, Ph.D., Dr Farid Rahimi, Prof. Iseult Lynch, Mirella Walker, Dr Luca Galluzzi, Sophie Ohlsson, Professor Tullio Florio, Dr Rabea A Gadelkareem, Dr Azubuike Christian Ukubuiwe, Prof Gajendra PS Raghava, Prof Jun Shen, Lubna Razak, ABHISHEKA BANSAL, Craig Billington, Dr Alejandro Lazo-Langner, Joan Albiol, MOURAD TAYEBI, Chuang Ma, Christine Toelzer , Dr. Kathrin Karsay, Professor Andrew M Beale, Professor Hugh James Byrne, Dr Ugo Marzocchi, Ana Nordberg, Martin Bartas, Natalia Echeverría, Dr Patricia M Graves

  62. Aptamers Selected for Recognizing Amyloid β-Protein—A Case for Cautious Optimism

    Article • International Journal of Molecular Sciences, February 2018, MDPI AG

    Dr Farid Rahimi

  63. Aptamers Selected for Recognizing Amyloid β-protein—A Case for Cautious Optimism

    Article • February 2018, MDPI AG

    Dr Farid Rahimi

  64. Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity

    Article • ACS Chemical Neuroscience, July 2016, American Chemical Society (ACS)

    Dr Farid Rahimi

  65. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells

    Article • Journal of Biological Chemistry, April 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Farid Rahimi

  66. Modulators of Amyloid β-Protein (Aβ) Self-Assembly

    Article • January 2016, Elsevier

    Dr Farid Rahimi

  67. Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders

    Article • September 2014, Bentham Science Publishers

    Dr Farid Rahimi, Dr Gal Bitan

  68. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01

    Article • Translational Neuroscience, January 2013, De Gruyter

    Dr Farid Rahimi

  69. Zn2+-Aβ40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons

    Article • Journal of Biological Chemistry, April 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Farid Rahimi

  70. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases

    Article • January 2012, Springer Science + Business Media

    Dr Farid Rahimi

  71. Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins

    Article • December 2011, Springer Science + Business Media

    Dr Farid Rahimi

  72. Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

    Article • Journal of Visualized Experiments, May 2010, MyJove Corporation

    Dr Farid Rahimi

  73. RNA Aptamers Generated against Oligomeric Aβ40 Recognize Common Amyloid Aptatopes with Low Specificity but High Sensitivity

    Article • PLOS One, November 2009, PLOS

    Dr Farid Rahimi

  74. Amyloids and Protein Aggregation-Analytical Methods

    Article • September 2009, Wiley

    Dr Farid Rahimi

  75. Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

    Article • Brain Pathology, July 2009, Wiley

    Dr Farid Rahimi

  76. Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture

    Article • The Journal of Immunology, June 2009, The American Association of Immunologists

    Dr Farid Rahimi

  77. Photo-Induced Cross-Linking of Unmodified Proteins (PICUP) Applied to Amyloidogenic Peptides

    Article • Journal of Visualized Experiments, January 2009, MyJove Corporation

    Dr Farid Rahimi

  78. Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders

    Article • Current Alzheimer Research, June 2008, Bentham Science Publishers

    Dr Farid Rahimi

  79. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease

    Article • Neurobiology of Aging, November 2006, Elsevier

    Dr Farid Rahimi

  80. Antigen-Epitope Retrieval To Facilitate Proteomic Analysis of Formalin-Fixed Archival Brain Tissue

    Article • Analytical Chemistry, October 2006, American Chemical Society (ACS)

    Dr Farid Rahimi

  81. S100A8 and S100A9 in Human Arterial Wall

    Article • Journal of Biological Chemistry, October 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Farid Rahimi

  82. FGF-2, IL-1β and TGF-β regulate fibroblast expression of S100A8

    Article • FEBS Journal, May 2005, Wiley

    Dr Farid Rahimi

  83. Regulation of S100A8 by Glucocorticoids

    Article • The Journal of Immunology, February 2005, The American Association of Immunologists

    Dr Farid Rahimi

  84. Probing the S100 protein family through genomic and functional analysis

    Article • Genomics, July 2004, Elsevier

    Dr Farid Rahimi

  85. Pick bodies in a family with presenilin-1 Alzheimer's disease

    Article • Annals of Neurology, January 2004, Wiley

    Dr Farid Rahimi